Sudmedica Quillota SA

Sudmedica Quillota SA exhibits a strong liquidity position, with a current ratio of 3.82, indicating that the company holds significantly more current assets than current liabilities. The company has no long-term debt, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with no leverage. However, the company's operating cash flow is negative at -298.6 million CLP, which may raise concerns about its ability to sustain operations without external financing.

Profitability metrics for Sudmedica Quillota SA are negative, with a return on equity of -2.82% and a return on assets of -2.17%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. The operating income is also negative at -146.5 million CLP, and the net income is -151.3 million CLP, reflecting a significant financial loss.

The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. There is no geographic diversification information available, but the company is based in Chile, suggesting that its operations are primarily domestic. This lack of diversification may expose the company to regional economic risks.

Sudmedica Quillota SA's growth trajectory is uncertain, as no outlook data is available for the current or next fiscal year. The company's recent financial performance, characterized by negative operating and net income, suggests a challenging operating environment. Without a clear growth strategy or improvement in financial performance, the company may struggle to attract investors or secure financing.

The risk assessment for Sudmedica Quillota SA indicates low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure is currently free of debt, and there is no indication of dilution pressure from recent equity issuances or shelf registrations. However, the company's negative operating cash flow and net loss may necessitate future financing, which could introduce new risks.

No recent events, such as filings or transcripts, are available to provide additional context on the company's operations or strategic direction. The absence of recent disclosures may limit the ability to assess the company's response to market conditions or its long-term viability.